South Dakota Administrative Rules › Title 44 - Department of Health › Article 44:70 - Assisted living centers › Chapter 44:70:04 - Management and administration › Section 44:70:04:10 - Tuberculin screening and testing requirements

Current through Register Vol. 51, page 10, July 15, 2024
Each facility shall develop criteria to screen healthcare
				  personnel or residents for
Mycobacterium
tuberculosis (TB)
				  based on the guidelines issued by Centers for Disease Control and Prevention.
				  Each facility shall establish policies and procedures for conducting TB risk
				  assessment that include the key components of responsibility, surveillance,
				  containment. The frequency of repeat screening shall depend upon annual
				  facility risk assessment results. Any resident identified as asymptomatic upon
				  admission as short stay or anticipated stay of thirty days or less is not
				  required to have tuberculin skin test or a TB blood assay test.
Tuberculin screening requirements for healthcare personnel
				  and residents are as follows:
(1) Each
				healthcare personnel or resident shall receive an initial individual TB risk
				assessment that is documented and the two-step method of tuberculin skin test
				or a TB blood assay test to establish a baseline within twenty-one days of
				employment or admission to a facility. Any two documented tuberculin skin tests
				completed within a twelve-month period prior to the date of admission or
				employment are considered two-step. A TB blood assay test completed within a
				twelve-month period prior to the date of admission or employment is considered
				an adequate baseline test. Skin testing or TB blood assay tests are not
				necessary if a new healthcare personnel or resident transfers from one licensed
				healthcare facility to another licensed healthcare facility within this state
				if the facility received documentation of the last skin or blood assay TB
				testing completed within the prior twelve months. Skin testing or TB blood
				assay tests are not necessary if documentation is provided of a previous
				positive reaction to either test. Any healthcare personnel or resident who has
				a newly recognized positive reaction to the skin or TB blood assay test shall
				have a medical evaluation and a chest X-ray to determine the presence or
				absence of the active disease;
(2)
				Each healthcare personnel or resident who provides documentation of a positive
				reaction to the tuberculin skin or a TB blood assay test shall have a medical
				evaluation and chest X-ray to determine the presence or absence of the active
				disease; and
(3) Each healthcare
				personnel or resident with a history of a positive reaction to the tuberculin
				skin test or TB blood assay test shall be evaluated annually by a physician,
				physician assistant, nurse practitioner, clinical nurse specialist, or a nurse
				and a record maintained of the presence or absence of symptoms of TB. If this
				evaluation results in suspicion of active tuberculosis, the healthcare
				personnel or resident shall be referred for further medical evaluation to
				confirm the presence or absence of tuberculosis;
(4) Each facility shall consider the use of
				annual TB screening for personnel at increased occupational risk and residents
				identified at increased risk for TB because of current or planned
				immunosuppression; and
(5) All
				healthcare personnel shall receive TB education annually. TB education shall
				include information on TB risk factors, the signs and symptoms of TB disease,
				and TB infection control policies and procedures.
General Authority:
SDCL
					 34-12-13(1)(5),
					 34-22-9(8).
Law Implemented:
SDCL
					 34-12-13(1)(5).
Tuberculosis Screening, Testing, and Treatment of
					 U.S. Health Care Personnel: Recommendations from the National Tuberculosis
					 Controllers Association and CDC, 2019
. "Centers for Disease Control and
					 Prevention Morbidity and Mortality Weekly Report," May 17, 2019 /
					 68(19);439-443.